EPOXYCYCLOHEXENEDIONE DERIVATIVE
    2.
    发明授权
    EPOXYCYCLOHEXENEDIONE DERIVATIVE 失效
    环氧环己烯衍生物

    公开(公告)号:EP0670317B1

    公开(公告)日:2000-03-08

    申请号:EP94927068.0

    申请日:1994-09-20

    IPC分类号: C07D303/36 A61K31/335

    CPC分类号: C07D303/36

    摘要: An epoxycyclohexenedione derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R represents C10-C25 linear or branched alkanoyl, C10-C25 linear alkenoyl or a group represented by formula (A), wherein n represents an integer of 1 to 4. This compound has antibacterial and antitumoral activities.

    摘要翻译: 通式(I)表示的环氧基环己二酮衍生物或其药理学上允许的盐,式中,R表示碳原子数10〜25的直链状或支链状的烷酰基,碳原子数10〜25的直链烯酰基或式(A)所示的基团, 到4.这种化合物具有抗菌和抗肿瘤活性。

    PROCESS FOR PRODUCING DISACCHARIDES AND NOVEL SACCHARIDES
    4.
    发明公开
    PROCESS FOR PRODUCING DISACCHARIDES AND NOVEL SACCHARIDES 失效
    VERFAHREN ZUR HERSTELLUNG VON DISACCHARIDEN UND SACCHARIDEN

    公开(公告)号:EP0717047A1

    公开(公告)日:1996-06-19

    申请号:EP94932166.5

    申请日:1994-12-08

    IPC分类号: C07H3/08 C12P19/12 C12N9/96

    CPC分类号: C07H3/04 C12P19/12

    摘要: A process for producing a disaccharide by conducting the condensation reaction of β-glucose-1-phosphate with a monosaccharide in an aqueous medium in the presence of an enzyme source originating in a microorganism of the genus Cattellatospora , Kineosporia , Propionibacterium or Enterococcus and having a sugar phosphorolytic activity, and harvesting the disaccharide formed in the medium. The obtained novel disaccharides are useful as medicine, food, cosmetic and enzyme stabilizer.

    摘要翻译: 一种通过在起源于卡特拉菌属(Cattellatospora),动球菌属(Kateosporia),丙酸杆菌属(Proinibacterium)或肠球菌属(Enterococcus)的微生物的酶源的存在下,在水性介质中进行β-葡萄糖-1-磷酸与单糖的缩合反应来生产二糖的方法, 糖溶解活性,并收获培养基中形成的二糖。 获得的新型二糖可用作药物,食品,化妆品和酶稳定剂。

    EPOXYCYCLOHEXENEDIONE DERIVATIVE
    6.
    发明公开
    EPOXYCYCLOHEXENEDIONE DERIVATIVE 失效
    环氧环己烯衍生物

    公开(公告)号:EP0670317A1

    公开(公告)日:1995-09-06

    申请号:EP94927068.0

    申请日:1994-09-20

    IPC分类号: C07D303/36 A61K31/335

    CPC分类号: C07D303/36

    摘要: An epoxycyclohexenedione derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R represents C₁₀-C₂₅ linear or branched alkanoyl, C₁₀-C₂₅ linear alkenoyl or a group represented by formula (A), wherein n represents an integer of 1 to 4. This compound has antibacterial and antitumoral activities.

    摘要翻译: 由通式(Ⅰ)表示的环氧环己烯二酮衍生物或其药理学上可接受的盐,其中R代表C 10 -C 25直链或支链烷酰基,C 10 -C 25直链烯酰基或式(A)代表的基团,其中n代表整数1 到4.这种化合物具有抗菌和抗肿瘤活性。

    FARNESYLTRANSFERASE INHIBITOR
    7.
    发明公开
    FARNESYLTRANSFERASE INHIBITOR 失效
    法尼基转移酶抑制剂。

    公开(公告)号:EP0670314A1

    公开(公告)日:1995-09-06

    申请号:EP94927069.8

    申请日:1994-09-20

    摘要: A farnesyltransferase inhibitor and an antitumor drug each containing a piperazinedione derivative represented by general formula (I) as the active ingredient, wherein R¹ and R² are the same or different from each other and each represents lower alkyl, lower alkoxyalkyl, or (un)substituted aryl or aralkyl; R³ and R⁴ are the same or different from each other and each represents mercapto, lower alkanoylthio, aroylthio, lower alkoxycarbonylthio or aryloxycarbonylthio, or R³ and R⁴ are combined with each other to represent a disulfide bond; and R⁵ and R⁶ are the same or different from each other and each represents hydrogen, lower alkyl, lower alkoxyalkyl, hydroxyalkyl, lower alkanoyloxyalkyl, aroyloxyalkyl, aralkyloxyalkyl or aralkyl.

    LK6-A DERIVATIVES
    9.
    发明公开
    LK6-A DERIVATIVES 有权
    LK6-A-衍生物

    公开(公告)号:EP1097934A1

    公开(公告)日:2001-05-09

    申请号:EP99929753.4

    申请日:1999-07-08

    IPC分类号: C07D471/06 A61K31/47

    CPC分类号: C07D471/06

    摘要: LK6-A derivatives represented by general formula (I) and pharmacologically acceptable salts thereof, which exhibit immunosuppressive, cytostatic and antitumor effects and so on, wherein R 1 is a lower alkanoyl or acryloyl group which may be substituted with, e.g., lower alkoxy, or the like; R 2 is hydrogen, halogeno or the like; R 2' is hydrogen, or R 2' together with R 3 forms a bond; R 3 is optionally substituted lower alkanoyl, or R 3 together with R 2' forms a bond; R 4 and R 5 are each hydrogen, optionally substituted lower alkanoyl or the like; R 6 is hydrogen or the like; and R 7 and R 8 are each hydrogen, optionally substituted lower alkanoyl or the like, with the proviso that LK6-A corresponding to a compound of general formula (I) where R 1 is (E)-methoxyacryloyl; R 2 , R 4 , R 5 , R 6 and R 7 are each hydrogen; R 8 is acetyl; and R 2' and R 3 together form a bond is excepted.

    摘要翻译: 具有通式(I)表示的LK6-A衍生物及其药理学上可接受的盐,其具有免疫抑制,细胞抑制和抗肿瘤作用等,其中R 1为低级烷酰基或丙烯酰基,其可被例如较低级 烷氧基等; R 2是氢,卤素等; R 2是氢,或R 2与R 3一起形成键; R 3是任选取代的低级烷酰基,或R 3与R 2'一起形成键; R 4和R 5各自为氢,任选取代的低级烷酰基等; R 6是氢等; R 7和R 8各自为氢,任选取代的低级烷酰基等,条件是对应于通式(I)的化合物的LK6-A,其中R 1为(E) - 甲氧基丙烯酰基 ; R 2,R 4,R 5,R 6和R 7各自为氢; R 8是乙酰基; 和R 2'和R 3一起形成键。